143
Participants
Start Date
December 31, 2015
Primary Completion Date
August 31, 2017
Study Completion Date
January 31, 2018
Rituximab
375 mg/m2 IV on day 1 of each 21 days chemotherapy cycle. Number of Cycles: 8.
Doxorubicin
50 mg of doxorubicin per square meter administrated IV on day 1 of each chemotherapy cycle
Vincristine
1.4 mg of vincristine per square meter, up to a maximal dose of 2 mg, administrated IV on day 1 of each chemotherapy cycle
Cyclophosphamide
750 mg of cyclophosphamide per square meter of body-surface area administrated IV on day 1 of each chemotherapy cycle
prednisone
100 mg of prednisone administrated PO per day for five days, day 1-5 of each chemotherapy cycle
Institut of Oncology, Hematology Department, Chisinau
CH Merkur, Zagreb
CHC Zagreb, Zagreb
Clinical Hospital Center Zemun, Belgrade
Clinical Hospital Center Zvezdara, Belgrade
Military Hospital Academy, Belgrade
Vinnitsya Regional Clinical Oncology Dispensary, Chemotherapy Department,, Vinnitsya
"Utility Enterprise Kirovograd regional oncology dispensary", Kirovohrad
"GH dr.Josip Bencevic", Slavonski Brod
Poltava regional oncology hospital, heamotherapy department, Poltava
Volyn' Regional clinical hospital, Haematology Department, Lutsk
"Municipal Institution Dnipropetrovsk City multi-field Clinical Hospital #4, Oncology and medical radiology department", Dnipropetrovsk
Kryvyi Rih Oncology Dispensary, Dnipropetrovsk Highway, Kryvyi Rih
Mykolayiv Region Clinical Hospital, Heamotology department, Mykolayiv
"Public utility Chernivtsi regional clinical oncology dispensary, Day patient department", Chernivtsi
Kharkiv Regional Clinical Oncology Centre, Deartment of haematology, Kharkiv
Regional Oncology dispensary, Zaporizhzhia
Zaporizhzhya Regional Clinical Hospital, Deartment of haematology and intensive therapy, Zaporizhzhia
Regional Clinical Hospital of Ivano-Frankivsk, Hematology Department., Ivano-Frankivsk
Regional Clinical Oncology Dispensary, Chemotherapy Department, Ivano-Frankivsk
"State institution Institute for haemotopathology and haemotransfusion of National Academy of science of Ukraine", Lviv
Regional clinical Hospital named after Novak, Hematology Department, Uzhhorod
University Clinical Center Banja Luka, Banja Luka
University Clinical Center Sarajevo, Sarajevo
University Clinical Center Tuzla, Tuzla
General Hospital Zenica, Zenica
HEMA, Tbilisi
S. Khechinashvili state University clinic, Tbilisi
Medulla - Chemotherapy and Immunotherapy Clinic, Tbilisi
Wojewódzki Szpital Specjalistyczny w Legnicy, Oddział Hematologiczny, Legnica
Samodzielny Publiczny Szpital Kliniczny nr1, Klinika Hematologii i Transplantacji Szpiku, Lublin
Szpital Wojewódzki w Opolu, Oddział Hematologii i Onkologii Hematologicznej, Opole
MTZ Clinical Research Sp. Z o.o., Warsaw
National Institute of Cancer, Department of chemotherapy, Kiev
Kiev City Clinical Oncological Center, Department of chemotherapy #2, Kiev
Lead Sponsor
Mabion SA
INDUSTRY